Analysis

Glaxosmithkline Pharmaceuticals Limited (GLAXO) Stock Analysis

Glaxosmithkline Pharmaceuticals Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to GLAXO.

websiteGLAXO/analysis/GLAXO

Glaxosmithkline Pharmaceuticals Limited

Glaxosmithkline Pharmaceuticals Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to GLAXO.

Stock profile

Ticker

GLAXO

Asset type

Stock

Market cap

$4.07B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

INR

Ticker listings

Glaxosmithkline Pharmaceuticals Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • GLAXO primary listing

Latest Glaxosmithkline Pharmaceuticals Limited news

Press Release May 13 2026

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated 0 , , titled "Press release ".

Press Release Feb 09 2026

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Press Release".

Press Release Nov 06 2025

Press Release

Press Release Aug 25 2025

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 25, 2025, titled "Company forays into Oncology lwith Jemperli and Zejula...

Press Release Aug 01 2025

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 01, 2025, titled "Media release: Q1 of 2025-26".

Research sections

Valuation

Review valuation context for Glaxosmithkline Pharmaceuticals Limited.

Future growth

Review future growth context for Glaxosmithkline Pharmaceuticals Limited.

Past performance

Review past performance context for Glaxosmithkline Pharmaceuticals Limited.

Financial health

Review financial health context for Glaxosmithkline Pharmaceuticals Limited.

Dividend

Review dividend context for Glaxosmithkline Pharmaceuticals Limited.

Management

Review management context for Glaxosmithkline Pharmaceuticals Limited.

Ownership

Review ownership context for Glaxosmithkline Pharmaceuticals Limited.

Other information

Review other information context for Glaxosmithkline Pharmaceuticals Limited.

Community

Review community context for Glaxosmithkline Pharmaceuticals Limited.